AAAAAA
Results:
1-8
|
Results: 8
Authors:
XU SC
KHOO S
DANG A
WITT S
DO V
ZHEN E
SCHAEFER EM
COBB MH
Citation: Sc. Xu et al., DIFFERENTIAL REGULATION OF MITOGEN-ACTIVATED PROTEIN ERK KINASE (MEK)1 AND MEK2 AND ACTIVATION BY A RAS-INDEPENDENT MECHANISM, Molecular endocrinology, 11(11), 1997, pp. 1618-1625
Authors:
KHOO S
COBB MH
Citation: S. Khoo et Mh. Cobb, ACTIVATION OF MITOGEN-ACTIVATING PROTEIN-KINASE BY GLUCOSE IS NOT REQUIRED FOR INSULIN-SECRETION, Proceedings of the National Academy of Sciences of the United Statesof America, 94(11), 1997, pp. 5599-5604
Authors:
VEAL GJ
HOGGARD PG
BARRY MG
KHOO S
BACK DJ
Citation: Gj. Veal et al., INTERACTION BETWEEN LAMIVUDINE (3TC) AND OTHER NUCLEOSIDE ANALOGS FORINTRACELLULAR PHOSPHORYLATION, AIDS, 10(5), 1996, pp. 546-548
Authors:
BACK D
VEAL G
KHOO S
BARRY M
Citation: D. Back et al., IN-VITRO ACTIVATION OF NUCLEOSIDE ANALOG DRUGS USED IN COMBINATION INTHE MRC QUATTRO TRIAL, AIDS, 10, 1996, pp. 27-27
Authors:
PHIBOONBANAKIT D
KHOO S
WATANAGOON Y
NABANGCHANG K
HOGGARD P
GIBBONS S
BARRY M
BACK D
Citation: D. Phiboonbanakit et al., ZIDOVUDINE PHOSPHORYLATION IN HIV-INFECTED THAI PATIENTS, AIDS, 10, 1996, pp. 28-28
Authors:
HOGGARD P
KHOO S
BARRY M
BACK D
Citation: P. Hoggard et al., INTRACELLULAR METABOLISM OF ZIDOVUDINE AND STAVUDINE IN COMBINATION, The Journal of infectious diseases, 174(3), 1996, pp. 671-672
Authors:
WINSTANLEY P
KHOO S
SZWANDT S
EDWARDS G
WILKINS E
TIJA J
COKER R
MCKANE W
BEECHING N
WATKIN S
BRECKENRIDGE A
Citation: P. Winstanley et al., MARKED VARIATION IN PYRIMETHAMINE DISPOSITION IN AIDS PATIENTS TREATED FOR CEREBRAL TOXOPLASMOSIS, Journal of antimicrobial chemotherapy, 36(2), 1995, pp. 435-439
Authors:
QUINN M
MURRAY J
FRIEDLANDER M
STEIGRAD S
KHOO S
MARSDEN D
HAMMOND I
JOBLING T
Citation: M. Quinn et al., EMACO IN HIGH-RISK GESTATIONAL TROPHOBLAST DISEASE - THE AUSTRALIAN EXPERIENCE, Australian and New Zealand Journal of Obstetrics and Gynaecology, 34(1), 1994, pp. 90-92
Risultati:
1-8
|